Prostate specific antigen testing: advice for well men aged 50 and over
- Public Health England
- Part of:
- Prostate cancer risk management programme: supporting documents
- First published:
- 1 January 2009
- Last updated:
- 29 March 2016, see all updates
This prostate cancer risk management programme (PCRMP) information is to help GPs advise well men aged 50 and over who ask about PSA testing.
PSA (prostate specific antigen) testing for prostate cancer: information for well men considering a PSA test
PDF, 1.73MB, 2 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
Any man can make an appointment with their GP to discuss having the prostate specific antigen (PSA) test.
This summary information sheet is for GPs to give to asymptomatic men aged 50 and over who proactively raise the issue of PSA testing.
It sets out the role of the PSA test in testing for prostate cancer. It gives men concise, clear and balanced information on the potential benefits and risks of having the test.
The document includes information about:
- the prostate
- prostate cancer
- the PSA test
- options after the PSA test
Published: 1 January 2009
Updated: 29 March 2016
- The summary information sheet for asymptomatic men aged 50 and over is being updated as part of the publication of the revised Prostate Cancer Risk Management Programme (PCRMP) information in March 2016
- First published.